Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.45 |
| ▸ | LTA4H | P09960 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.39 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NPY1R | P25929 | 1/20 | 0.38 |
| ▸ | NPY2R | P49146 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29363526 | 0.85 | LTA4H (0.52) | L3MBTL1TDP1GAASLC2A1LTA4H | |
| SCHEMBL442080 | 0.85 | LTA4H (0.52) | L3MBTL1TDP1GAASLC2A1LTA4H | |
| SCHEMBL10488258 | 0.84 | GAA (0.44) | L3MBTL1TDP1GAASLC2A1CYP1A2 | |
| SCHEMBL10488312 | 0.83 | L3MBTL1 (0.41) | L3MBTL1TDP1GAACYP1A2CYP2C9 | |
| SCHEMBL9466054 | 0.83 | PADI4 (0.43) | L3MBTL1TDP1GAASLC2A1ADRB2 | |
| SCHEMBL27262240 | 0.81 | LTA4H (0.48) | L3MBTL1TDP1GAASLC2A1LTA4H | |
| SCHEMBL10488272 | 0.81 | PADI4 (0.44) | L3MBTL1TDP1GAAADRB2ADRB1 | |
| SCHEMBL28075742 | 0.80 | LTA4H (0.47) | L3MBTL1TDP1GAASLC2A1LTA4H | |
| SCHEMBL600606 | 0.79 | LTA4H (0.52) | L3MBTL1TDP1GAALTA4HCYP1A2 | |
| SCHEMBL347692 | 0.79 | LTA4H (0.50) | L3MBTL1TDP1GAASLC2A1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2270114-B1 | PHOTOBASE GENERATOR | SAN APRO LTD (JP) | 2014-07-09 | — | — | EP | disclosed |
| US-8329771-B2 | Photobase generator | SAN-APRO LIMITED (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20110028585-A1 | PHOTOBASE GENERATOR | SAN-APRO LIMITED (JP) | 2011-02-03 | — | — | US | disclosed |
| EP-2270114-A1 | PHOTOBASE GENERATOR | San-Apro Limited (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-4803226-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1989-02-07 | — | — | US | disclosed |
| US-4803221-A | Anthracene derivatives | BURROUGHS WELLCOME CO. (US) | 1989-02-07 | — | — | US | disclosed |
| EP-0125701-B1 | POLYCYCLIC AROMATIC COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-08-03 | — | — | EP | disclosed |
| US-4719047-A | ANTITUMOR | BURROUGHS WELLCOME CO. (US) | 1988-01-12 | — | — | US | disclosed |
| US-4719049-A | ANTITUMOR | BURROUGHS WELLCOME CO. (US) | 1988-01-12 | — | — | US | disclosed |
| EP-0125701-A2 | Polycyclic aromatic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028585-A1 | PHOTOBASE GENERATOR | CCKBR, XDH, PPOX | L3MBTL1 3526/4885TDP1 872/4885GAA 870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.